Background: To evaluate the impact of treatment of symptomatic convergence insufficiency using office-based vergence/accommodative therapy on reading skills in children. Methods: Children (n = 44) ages nine to 17 years with symptomatic convergence insufficiency were administered the following four reading tests: Wechsler Individual Achievement Test II; Test of Word Reading Efficiency; Test of Silent Word Reading Fluency; and the Gray Oral Reading Test, at baseline and eight weeks after completion of a 16-week program of office-based vergence/accommodative therapy. To determine whether significant change occurred with therapy, change in performance was compared to zero. Treatment response was determined using a composite score of symptoms and signs at the conclusion of treatment and at the 24-week outcome visit. Participants were classified as early responders, late responders, or non-responders based upon whether criteria for successful treatment were met at the completion of 16 weeks of treatment, at the 24-week outcome visit, or not met at either visit, respectively. Results: After treatment for convergence insufficiency, statistically significant improvements were found for reading comprehension (mean = 4.2, p = 0.009) and the reading composite score (mean = 2.4, p = 0.016) as measured by the Wechsler Individual Achievement Test at the 24-week visit. These improvements were related to the clinical treatment outcome measures (p = 0.011) with the largest improvements occurring in those who were early responders to treatment. Reading speed (words per minute) increased significantly on the Gray Oral Reading Test (p < 0.0001). No significant improvements were observed for single word reading or reading fluency as measured by the Test of Word Reading Efficiency, the Test of Silent Word Reading Fluency or the Gray Oral Reading Test. Conclusion: Improvements in reading comprehension and reading composite were found after office-based vergence/accommodative therapy, with the greatest improvements in those who responded early to treatment.
place and double vision during reading may deleteriously impact the attention needed for the task of reading. Recent studies have demonstrated that after successful treatment for symptomatic CI, children report fewer symptoms when reading 5, 6 and their parents report a reduction in academic-impairing behaviours. 4 Studies have suggested that children with CI and reading difficulties who undergo treatment for their CI show improvements in reading performance, [7] [8] [9] including better reading comprehension, 8, 9 speed 7,9 and accuracy. 7, 9 In fact, Atzmon et al. 8 reported that their orthoptic treatment program was equally as effective in improving reading skills as was conventional in-school reading tutoring. However, these studies varied considerably in terms of diagnostic criteria, treatments administered, outcome measures, and importantly, none were rigorous randomised clinical trials. Thus, at present, there is no definitive evidence that the treatment of CI in symptomatic children leads to improvements in reading.
The impact of office-based vergence/ accommodative therapy with home reinforcement (OBVAT) 5, 10, 11 on reading performance in children with symptomatic CI has not been investigated. In preparation for a large-scale randomised clinical trial to evaluate this question, the prospective pilot study reported on herein was designed to determine if improvements in reading performance occurred after children with symptomatic CI were treated with OBVAT. The present study was also designed to provide a preliminary estimate of the effect of treatment so that this information could be used to estimate sample size for a randomised trial.
METHODS
The tenets of the Declaration of Helsinki were followed throughout the study. The institutional review boards of all participating centres approved the protocol and informed consent forms. The parent or guardian (subsequently referred to as 'parent') of each study patient gave written informed consent and each patient gave written assent to participate. Health Insurance Portability and Accountability Act authorisation was obtained from the parent.
Participants
Children were enrolled into the Convergence Insufficiency Treatment TrialReading Study (CITT-RS) from seven clinical sites (Appendix S1). Major eligibility criteria included the following: age nine to 17 years inclusive, exophoria at near at least 4 Δ greater than at far, a receded near point of convergence (NPC) break of 6 cm or greater, and insufficient positive fusional vergence at near (PFV) (that is, failing Sheard's criterion 12 [PFV less than twice the near phoria] or minimum PFV of 15
Δ base-out break), a Convergence
Insufficiency Symptom Survey (CISS) score of ≥ 16, 1,13 and a monocular accommodative amplitude of > 5.00 D. An optical correction was required for predetermined refractive error as defined below. In addition, English needed to be the primary language spoken at home or the child had to be proficient in English as determined by the child's school. Complete inclusion and exclusion criteria can be found in Table 1 .
Study timeline
All eligibility and outcome testing had to occur while the child was still in school or within two weeks of school ending for the summer. By assuring that OBVAT and follow-up testing both occurred while the
Inclusion criteria
1. Ages 9-17 years 2. IQ better than 80 (K-BIT-2) 3. Best corrected visual acuity of 6/7.5 or better in each eye at distance and near 4. Exophoria at near at least 4 Δ greater than at far 5. Insufficient positive fusional convergence (that is, failing Sheard's criterion or positive fusional vergence < 15 Δ base-out blur or break) 6. Receded near point of convergence of ≥ 6 cm break 7. Appreciation of random dot stereopsis using a 500 seconds of arc target 8. Convergence Insufficiency (CI) Symptom Survey score ≥ 16 9. No previous CI treatment with office-based vergence/accommodative therapy with home reinforcement 10. Willing to wear appropriate refractive correction 11. Willing to discontinue use of base-in prism, bifocals or plus at near 12. Have access to a computer to perform the computerised home therapy procedures 13. If new glasses or a change in prescription is necessary, the subject must be willing to wear the new glasses and return in two weeks for eligibility testing 14. Must have had a cycloplegic refraction within the last two months 15. English as the primary language spoken at home or proficient in English as determined by the school Exclusion criteria 1. ≥ 2 Δ esophoria at distance 2. Significant hearing loss 3. Substance abuser as indicated by a response of two on either item 2 or item 105 of the Child Behaviour Checklist 4. Developmental disability, attention deficit hyperactivity disorder, or learning disability diagnosis in children that in the investigator's discretion would interfere with the testing regimen 5. Amblyopia (≥ 2 lines difference in best corrected visual acuity between the two eyes) 6. Constant strabismus 7. History of strabismus surgery 8. High refractive error based on cycloplegic refraction: myopia ≥ 6.00 D sphere, hyperopia ≥ 5.00 D sphere, astigmatism ≥ 4.00 D 9. Anisometropia ≥ 2.0 D spherical equivalent 10. Prior refractive surgery 11. Vertical heterophoria > 1 Δ 12. Systemic diseases known to affect accommodation, vergence and ocular motility such as: multiple sclerosis, Graves thyroid disease, myasthenia gravis, diabetes, Parkinson's disease 13. Accommodative amplitude greater than 20 cm in either eye as measured by the Donder's push-up method 14. Manifest or latent nystagmus 15. CI secondary to acquired brain injury or any other neurological disorder In addition to the above-mentioned vision testing, the CITT-RS examiner also administered the Kaufman Brief Intelligence Test Version 2, which is a measure of verbal (vocabulary subtest) and nonverbal (matrices subtest) cognitive ability. A score of ≥ 80 was required to be eligible for the study.
Reading assessment
Participants were administered the following four reading tests in sequential order: the Wechsler Individual Achievement Test, 2nd Edition (WIAT-II), the Gray Oral Reading Test (GORT-4), the Test of Word Reading Efficiency (TOWRE), and the Test of Silent Word Reading Fluency (TOSWRF). All tests were administered and scored manually according to the guidelines of the publisher. The TOWRE, TOSWRF and GORT-4 tests have two different versions of test forms that were used for pre-and post-treatment testing; there is only one form available for the WIAT-II, so the same form was used for at baseline and outcome.
Reading tests WIAT-II
This test has three subtests (word reading, pseudo-word reading and reading comprehension). Word reading requires reading words aloud from lists; pseudo-word decoding requires reading nonsense words aloud from a list, and reading comprehension requires the reading of passages silently or aloud (child chooses) and then having the child answer questions about what was read. In addition, the time taken to read the passages provides a measure of reading speed. The standard scores for the three subtests are combined into a reading composite scale.
GORT-4
The GORT-4 measures oral reading speed and accuracy, as well as reading comprehension. Different forms were used preand post-testing. The speed and accuracy scores are combined into an oral reading fluency score. In addition, the speed of each child was measured as the number of words read per minute. Because normative values were not available for reading speed, change in reading speed was determined for each child by comparing the rate of reading passages at the same grade level from the two test forms (pre-and posttreatment).
TOWRE
This test measures the ability of an individual to pronounce printed words (that is, sight word efficiency) and phonemically regular non-words (that is, phonemic decoding efficiency). The ability to read single words has been shown to be reduced in children with reading disorders such as dyslexia, the presence of which might limit any potential effects of CI treatment on improvements in reading fluency and comprehension. Although changes in decoding ability were not expected to occur in this study, the TOWRE was included to help in planning future randomised trials by allowing readers to assess whether decoding ability remained stable or was related to changes in other reading measures.
TOSWRF
This test measures the ability of the child to recognise printed words accurately and efficiently. A passage is presented with no spacing and the child is asked to place a mark between as many words as possible in three minutes.
The WIAT-II, TOWRE and TOSWRF use standardised scales with a mean of 100 and a standard deviation of 15. The GORT-4 is normed to a mean of 10 with a standard deviation of three. For all of the tests, higher scores indicate better reading performance.
Treatment protocol OBVAT
All participants received weekly 60-minute in-office OBVAT therapy visits for 16 weeks, with prescribed procedures to be performed at home for 15 minutes a day, five days per week. At each office visit, the patient performed four to five therapy procedures under the supervision of a therapist (optometrist with advanced training in vision therapy) who followed the CITT therapy protocol (CITT Manual of Procedures accessed at http://optometry.osu. edu/research/CITT/4363.cfm) which was modified from a 12-week to a 16-week protocol for this study. Although previous studies demonstrated OBVAT is effective for improving clinical measures after 12 weeks, we hypothesised that a longer period of therapy might be necessary to achieve changes in reading. This hypothesis was based on the idea that it might require a longer period of time for the child to realise reading might be more comfortable and begin to spend more time reading. Detailed instructions for each office-and home-based procedure are in the CITT Manual of Procedures.
Follow-up visits
A follow-up vision examination was performed upon completion of the 16-week OBVAT treatment program. Examiners administered the CISS and original visual functioning tests -cover testing, NPC, positive and negative fusional vergence at near, monocular accommodative amplitude and Treating convergence insufficiency Scheiman, Chase, Borsting et al. monocular accommodative facility. Because all participants received the same treatment, masking to treatment assignment was not possible. However, vision function testing was performed by an examiner masked to the participant's compliance with treatment. After the 16-week visit, participants were assigned home maintenance therapy, which consisted of one gross convergence and one fusional vergence therapy procedure to be performed for 15 minutes, once per week until the outcome examination at week 24.
24-week outcome examination
The outcome examination was performed 24 weeks from baseline testing and was comprised of the same visual function testing battery performed at baseline and at 16 weeks and the same reading tests performed at baseline. The hypothesis was that some children there may not obtain a short-term gain in reading, but after improved comfort as a result of successful therapy, some children may begin to read more often and subsequently show improvements in reading performance. Therefore, changes in the reading outcome measures may not occur in the short term after 16 weeks of therapy. Thus, four extra weeks were added to allow the child to experience reading with better comfort to provide a better chance of seeing changes in reading. The examiners conducting the vision testing were masked to the treatment compliance of the participants, and the examiners performing the reading testing were masked to participant compliance with treatment and results of the visual function testing.
Assessing response to OBVAT
A composite outcome classification that considered the change in CISS score (symptom level), the NPC, and PFV was used to assess the response to OBVAT. A 'successful' outcome was defined as a score of < 16 on the CISS, a normal NPC (that is, less than 6 cm), and normal PFV (that is, > 15 Δ and passing Sheard's criterion). 'Improved' was defined as a score of < 16 or a ≥ 10 point decrease in the CISS score, and at least one of the following: normal NPC, an improvement in NPC of ≥ 4 cm, normal PFV or an increase in PFV of > 10 Δ .
Response to treatment was determined using the composite classification at both weeks 16 and 24. 'Early' treatment responders were the participants who were classified as successful at the 16-week examination. Those who moved from improved or non-responder at 16 weeks to successful at 24 weeks were classified as 'late' treatment responders. All other children were classified as treatment non-responders.
Statistical methods
All statistical analyses were performed using SAS Version 9.2 (SAS Institute Inc., Cary, North Carolina, USA). Standardised scores (age norms) for reading measures, as opposed to raw scores, were used in all analyses to adjust for changes in reading due to normal development. In addition, the GORT-4 test was digitally recorded and transmitted to a centralised reading centre for re-scoring of the rate, accuracy and fluency subscales. When differences occurred, the reading centre scores were used for data analyses. Because of issues with recording and transmission, there were nine participants for whom rescored data was unavailable and therefore, these participants were excluded from the analyses for the GORT-4 only. Another three participants did not complete the GORT-4 on the follow-up visit, leaving a total sample of 36 for the GORT-4 analysis.
One-sample t-tests were used to compare the mean improvement for all reading test scores and reading speed to zero. For tests showing a significant improvement, the response to CI treatment was investigated by using an analysis of covariance (ANCOVA) to compare the improvement in reading test scores of early, late and non-responders. The reading test score at baseline was used as a covariate in the ANCOVA model.
Previous studies investigating the impact of convergence treatment on reading recruited only poor readers. However, in this study symptomatic CI children and adolescents were recruited and then their reading abilities were measured. This approach resulted in a wide variation in reading scores at baseline. In order to compare the results to previous studies, additional comparisons were performed for below-average performers (defined as those who scored 0.5 standard deviation [SD] or more below the mean on that test at baseline) and average or above average performers for each test. The mean improvement in each reading measure was compared to zero for both below average and average/above average readers. Agebased normative scores were used to account for changes in age during the study.
Statistical significance was assessed using an α-level of 0.05. Although this report includes results from a large number of statistical tests, no adjustments were made to control the overall error rate. At a fixed sample size, a reduction in the alpha error rate corresponds to an increase in the beta error rate (fail to reject H 0 when it is false). That is, by using a smaller alpha to judge statistical significance, the likelihood of missing true significant improvements in reading performance would increase. Because this pilot study was designed to generate hypotheses that could then be investigated further in subsequent rigorous randomised clinical trials, it was felt that it was important to maximise the ability to find improvements (that is minimise the beta error rate).
An effect size, Cohen's d, was computed and used to characterise the magnitude of improvements in reading performance. These effect sizes were compared to national norms using data from Bloom et al. 14 
RESULTS
Forty-eight children were enrolled. Study retention was excellent with 44 of the 48 (92 per cent) returning for the 24-week outcome examination. Only 35 (4.3 per cent) of the 822 scheduled therapy visits were missed.
The mean age at enrolment of those completing OBVAT was 11.4 years (range of nine to 16 years); 52 per cent were female. Fifty per cent were Caucasian and 41 per cent were African-American, with 27 per cent of Hispanic ethnicity. Parents reported that five (11 per cent) of the children had been diagnosed with attention deficit hyperactivity disorder. English was the primary language of the household for 91 per cent of participants. The mean CISS score of the participants was 30. Twenty-five (57 per cent) of the participants were 'early treatment responders' (that is, successful at 16 weeks) and 11 (25 per cent) participants were 'late treatment responders' (not meeting the success criteria until the 24-week outcome visit). The other eight participants were treatment non-responders (six nonresponders at both weeks 16 and 24, one non-responder at week 16 and improved at week 24, and one improved at both weeks 16 and 24). The clinical data at baseline, follow-up and outcome are shown in Table 2 .
The participants demonstrated a broad range of reading abilities with baseline reading scores ranging from three standard deviations below to more than three standard deviations above the age-normal population mean for all tests. The composite and subscale mean scores of the reading tests were not significantly different from the published norms except for the TOWRE sight word efficiency subscale (mean = 95.4, SD = 12.2, p = 0.009) and the TOWRE composite score (mean = 94.6, SD = 12.4, p = 0.003), which were significantly below published norms (mean = 100, SD = 15). Depending on the decoding test administered, only two or three participants had decoding standard scores < 80; therefore, it was not possible to compare the change in reading scores for children with decoding < 80 versus ≥ 80 to determine whether poor decoding skills limited the treatment response.
There were statistically significant improvements in the WIAT-II reading comprehension subtest score (mean improvement = 4.2, SD = 10.1, p = 0.009) and the WIAT-II composite score (mean improvement = 2.4, SD = 6.3, p = 0.016) ( Table 3) . Both poor performers (mean = 3.9, SD = 10.6, p = 0.30) and average or above performers (4.2, D = 10.1, p = 0.019) showed similar magnitude improvements, but the improvements in poor performers were not statistically significant, likely due to the small number of subjects in this group (n = 9). As with reading comprehension, the WIAT-II composite measure improved for both poor performers (mean = 2.5, SD = 6.5, p = 0.21, n = 12) and average or above performers (mean = 2.3, SD = 6.4, p = 0.046).
The improvements observed in reading comprehension as measured by the WIAT-II were related to treatment response (p < 0.001) with the largest improvements occurring in the early treatment responders (mean = 8.2). In fact, the improvement among early treatment responders was significantly greater than that observed in the late responders (mean = −1.2, p = 0.004) and non-responders (mean = −1.1, p = 0.005). Improvements in the WIAT-II composite measure were also significantly related to treatment response (p = 0.031), with the largest improvements among the early responders (mean = 4.2) and very little change in the late responders (mean = −0.1) and non-responders (mean = 0.1).
On the GORT-4, standardised scores of reading rate, accuracy and fluency did not show significant changes, but reading speed as measured in words per minute showed a 12 per cent improvement (p < 0.0001; Table 3 ). While the sample as a whole did not improve significantly with respect to GORT-4 reading comprehension, a significant improvement was observed among poor performers (mean = 2.9, SD = 3.1, p = 0.010).
For the sample as a whole, no significant improvements were observed in decoding or silent word reading fluency as measured by the TOWRE and TOSWRF ( Table 4 shows effect sizes over a 24-week treatment period for the WIAT-II reading scores. Grade sample sizes varied for different measures due to missing data. In Table 5 composite reading scores were compared to national annual norms 14 that were prorated to 24 weeks to match the duration of treatment in this study. Since reading skills improve more rapidly in the fall than the spring, 15 and children participated in our study throughout the school year, we controlled for the fall/spring bias by using annual norms for reference.
DISCUSSION
The impact of 16 weeks of OBVAT on reading performance in children nine to 17 years of age with symptomatic CI was evaluated and found to vary with the outcome measure. Significant improvements were found for reading comprehension and composite reading score as measured by the WIAT-II. These improvements were related to treatment outcome with the largest improvements occurring in those who were successfully treated for CI. The improvements were also significantly greater for early treatment responders (classified 'successful' at 16 weeks) compared to late treatment responders (classified 'successful' at 24 weeks). No significant improvements were observed in fluency as measured by the TOWRE, TOSWRF and GORT-4 tests, but reading speed (words per minute) on the GORT-4 showed a significant 12 per cent improvement after treatment. While the results cannot be directly compared to previous studies due to methodological differences, the results support the prior reports of improved reading comprehension and reading speed after therapy in poor readers with convergence problems. 8, 9 In previous large-scale randomised clinical trials that compared treatments for children with symptomatic CI, the most frequent symptoms were loss of place (49.8 per cent), loss of concentration (45.3 per cent), re-reading the same line (44.8 per cent) and reading slowly (40.3 per cent). 5, 16 The hypothesis was that these symptoms would likely have a detrimental effect on reading comprehension, reading fluency and reading rate, with minimal effect on decoding skills. Three of the four tests used in this study (WIAT-II, TOSWRF and GORT-4) were selected because the goal was to investigate the effect of successful treatment on different parameters of reading such as reading comprehension and fluency. The TOWRE and pseudo-word decoding from the WIAT were used as probes to help understand the impact of poor versus normal decoding skills on the impact of treatment for CI. The most significant change was observed for the WIAT-II reading comprehension subtest but significant changes in fluency as measured by the TOSWRF and GORT-4 tests were not observed. It could be that fluency changes following treatment are subtle and would not be detected in these standardised tests. This led to the analysis of the changes in words per minute on the pre-and posttreatment administration of the GORT-4 where a significant change from the baseline values was found. Changes in decoding skills as measured by the TOWRE and WIAT-II were not expected. The results are largely consistent with this hypothesis, except for the improvement seen in pseudo-word reading on the WIAT-II. This change was smaller than that found with the WIAT-II reading comprehension measure and was observed mainly in poor performers. It could be that poor readers may attend more to sound-symbol relationships tested for in pseudo-word decoding as the CI improves.
A significant improvement in reading comprehension on the WIAT-II was found but a similar result on the GORT-4 comprehension measure was not found. Different tests of reading comprehension often yield varying results as the administration and content are not similar across tests. 17 This does apply to the WIAT-II and GORT-4 tests. The GORT-4 does not allow the child to look at the passage while answering questions and the child is required to read orally. In contrast, on the WIAT-II the child can choose to read aloud or silently and is encouraged to view the passage while answering comprehension questions. In addition, the validity of the comprehension questions on the GORT tests has been questioned by research showing that performance on some test questions is independent of reading the passage. 18 Thus, the WIAT-II may be a more valid test of reading comprehension for assessing change in performance following treatment for CI.
While the results cannot be directly compared to previous studies due to methodological differences, the results support the prior reports of improved reading comprehension and reading speed after therapy in poor readers with convergence problems. 8, 9 Bloom et al.'s data suggest a normal rate of reading improvement over a 24-week period of school that ranges from an effect size of 0.03 in grade 11 to 0.28 in grade two (Table 5 ). Children in our study showed substantially better reading growth than was expected in all grade levels except grade four. Reading performance was highly variable in this group with baseline standard composite reading scores ranging from a low of 81 (10 per cent) to a high of 135 (99 per cent). The child with the lowest score of 81 may have benefitted from regression to the mean of 100 as her reading score improved to 95, whereas the child with a baseline score of 135 performed close to the ceiling of the test and had the largest reading performance decline in the study. This variability may be associated with the group's slower than average reading growth.
It is possible that greater improvements in reading would be observed if typical real-life reading passages were used for testing. Commercially available reading tests have essentially been designed to minimise the effect of vision problems during the evaluation of reading performance. The font size and line spacing is large and the reading sections tend to be short in length, thereby allowing the child to read for a short period of time with periods of visual rest while answering questions. This is in contrast with typical real-life experiences in which the font size is typically smaller and reading with comprehension is required for extended periods of time. Significant improvements in reading speed may be more likely when there is passage-reading that requires sustained eye-tracking. This difference between standardised reading assessments and typical real-life reading experiences complicates attempts to study the effect of treatment of vision problems on reading performance. This investigation was designed as a pilot study to prepare for a large-scale, randomised clinical trial. A number of significant limitations including a small sample size and absence of a control group are present in this study. However, the study has a number of strengths over the previous studies reporting the effect of treatment on reading performance in children with poor convergence ability. [7] [8] [9] First, we applied very specific eligibility criteria and implemented an identical treatment protocol for all participants. In addition, nearly all of the participants completed treatment and returned for their outcome visit. Furthermore, participants were evaluated using standardised measures, all examiners were masked to compliance with treatment of the participants, and the reading testing examiners were masked to the results of the visual function testing. Based on the results one would expect to find changes in reading tests for comprehension and reading fluency where reading rate is measured in words per minute. This may require the use of standardised tests along with curriculum-based measurements in future trials of treatment for CI.
Improvements in reading ability were found in children with symptomatic CI after OBVAT, with the greatest improvements occurring in reading comprehension and in those who responded early to treatment. A randomised treatment trial with a placebo control group, more participants and a longer period of follow-up is warranted. The hypothesis is that for some children there may not be a short-term gain in reading, but after improved comfort as a result of successful therapy, some children may begin to read more often and subsequently show improvements in reading performance. were pro-rated for a 24-week time period.
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